Hemoglobins Lepore and anti-Lepore

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Background:

• Hemoglobin Lepore (deltabeta) and anti-Lepore (betadelta) are structural hemoglobin variants arising from non-homologous crossing-over between delta and beta globin genes.
• Several Lepore and anti-Lepore variants have been identified, each with unique structural and genetic origins.

Purpose of the Study:

• To describe the structure, properties, genetics, and clinical and biochemical expression of hemoglobins Lepore and anti-Lepore.
• To present data on the hematological and biochemical expression and geographical distribution of these hemoglobin variants.

Main Methods:

• Structural identification of hemoglobin variants.
• Hematological and biochemical analyses.
• Genetic analysis of non-homologous crossing-over events.

Main Results:

• Hb Lepore presents phenotypically and clinically as beta thalassemia, distinguished by ~10% Hb Lepore content.
• Hb anti-Lepore does not exhibit phenotypic thalassemia due to the absence of beta chain deficiency.
• The low synthesis of Lepore and anti-Lepore chains may be due to rate-limiting steps from rare codons or mRNA instability.

Conclusions:

• Hemoglobin Lepore and anti-Lepore are products of delta-beta or beta-delta gene fusion.
• These variants provide a model for understanding globin gene regulation and the molecular basis of thalassemia.
• Further research is needed to fully elucidate the factors regulating the synthesis of these abnormal hemoglobins.